EU4H – Develop early warning features and guidance in the area of pricing through the EURIPID database, based on competition cases – 2022

EU4H - Develop early warning features and guidance in the area of pricing through the EURIPID database, based on competition cases, aiming at developing early warning mechanisms and guidance in the area of pricingthrough the EURIPID database, based on lessons from competition cases, in particular on excessive pricing.

2022-05-24

300,000 euro

Additional information

Additional regional information :

EU Member States (including overseas countries and territories linked to it (OCTs))
Eligible non-EU countries : listed EEA countries and countries associated to the EU4Health Programme or countries which are in ongoing negotiations for an association agreement and where the agreement enters into force before the deadline for submission

Amount :

To view this information , thank you for logging in.

Useful :

To view this information , thank you for logging in.

Sectors : Finance Health

Beneficiary : Local Authority & Affiliated Entity

Regions : Developing countries, European Economic Area, European Union

Category : Call for proposals

Manager : European Commission

Contact :

To view this information , thank you for logging in.

Priorities and funded actions

Objective

To develop early warning mechanisms and guidance in the area of pricing through the EURIPID database, based on lessons from competition cases, in particular on excessive pricing.

Priorities

Priority 1: create common approaches to verify claims on price information and to provide appropriate guidance to adjust pricing methodologies.
Priority 2: prevent price increases based on unfounded claims to recover investments and increased costs.

Among financed actions

Monitoring of strategic sequencing of price increases of threats to de-list reimbursable medicines or withdraw of medicines.

Additional information

This call for proposals is an open call for proposals
Initial duration of the action: between 12 and 36 months

Eligibility

Be legal entities (public or private bodies)
Be established in one of the eligible countries
A consortium composed of at least 6 eligible applicants established in at least 5 different eligible countries.

Similar news

14 February 2022

€1.3 billion for HERA first work plan – a step towards the European Health Union

Lire l'aticle

22 October 2021

€650 million investment to accelerate French digital health strategy

Lire l'aticle

EU4H – Develop early warning features and guidance in the area of pricing through the EURIPID database, based on competition cases – 2022

Additional information

Priorities and funded actions

Eurofunding gathers more than 300 European grant programs updated and linked to weekly alerts on calls for projects. Subscribe for free and don't miss any more opportunities.

Similar news

€1.3 billion for HERA first work plan – a step towards the European Health Union

€650 million investment to accelerate French digital health strategy